Animal Vaccine Market 2024: Industry Drivers, Growth Factors and Forecast by 2032

The latest report by IMARC Group, titled ‘Animal Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2032,' offers a comprehensive analysis of the animal vaccine market demand. The report also includes competitor and regional analysis, along with a breakdown of segments within the industry.

The global animal vaccine market size reached US$ 13.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 25.1 Billion by 2032, exhibiting a growth rate (CAGR) of 7.24% during 2024-2032.

Animal Vaccine Market Trends:

The global market is primarily driven by the rising prevalence of zoonotic diseases necessitating the widespread use of vaccines. In accordance with this, the growing livestock population to meet the increasing demand for meat and dairy products significantly supports the need for effective vaccination programs, thereby impelling the market. Similarly, continual advancements in vaccine technology, including the development of recombinant and DNA vaccines, is resulting in higher uptake of the product.

Furthermore, the increasing pet ownership and the consequent rise in spending on pet healthcare is driving the demand for companion animal vaccines, which in turn is facilitating market expansion. In addition to this, the expansion of the poultry and aquaculture industries, where vaccines are essential for disease prevention and productivity, is further propelling market demand.

Request to Get the Sample Report: https://www.imarcgroup.com/animal-vaccine-market/requestsample

Animal Vaccine Market Scope and Growth Analysis:

The scope of the market indicates a robust growth, driven by technological advancements and increasing awareness of animal health. The market scope is expected to expand due to the continuous development of novel vaccines that offer improved protection and ease of administration. Additionally, the rising trend of sustainable livestock farming, which emphasizes disease prevention through vaccination, is presenting new opportunities for growth in the market.

The increasing regulatory focus on animal welfare and the prevention of disease outbreaks in livestock populations is further impelling the market. As per market analysis, the growth of the veterinary healthcare infrastructure, particularly in emerging economies, is enhancing market access and vaccine distribution. Moreover, the rapid integration of digital technologies and data analytics in veterinary practices facilitates better disease monitoring and vaccine management, contributing to market efficiency.

Explore Full Report with Table of Contents: https://www.imarcgroup.com/animal-vaccine-market

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

• H. Boehringer Sohn AG & Co. KG
• Ceva Sante Animale
• Elanco Animal Health Incorporated (Eli Lilly and Company)
• Hester Biosciences Limited
• Hipra S.A.
• Hygieia Biological Laboratories
• Merck & Co. Inc.
• Phibro Animal Health Corporation
• Vaxxinova GmbH (EW Group)
• Virbae
• Zoetis Services LLC

Animal Vaccine Market Segmentation:

Our report has categorized the market based on region, product, animal type, route of administration.

Breakup by Product:

• Attenuated vaccines
• Inactivated vaccines
• Subunit vaccines
• Toxoid vaccines
• Conjugate vaccines
• Recombinant vaccines
• DNA vaccines Type

Breakup by Animal Type:

• Companion animal  
  • Dogs
  • Cats
• Livestock animal  
  • Cattle
  • Pigs
  • Poultry
  • Sheep
  • Others
• Aquaculture

Breakup by Route of Administration:

• Subcutaneous
• Intramuscular
• Intranasal
• Others

Breakup by Region:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:

• Market Performance (2018-2023)
• Market Outlook (2024-2032)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145